Takeda Pharmaceutical has appointed Ramona Sequeira as president of the U.S. business unit. In this role, Sequeira will lead all business operations for the U.S., and will report to Christophe Weber, the president and CEO of Takeda.

"The U.S. is a critical market for Takeda's future growth, and I am confident that with her strong commercial experience and knowledge of the U.S. healthcare environment, Ramona is the right person to lead this important business unit and play a key role on my leadership team," said Weber. "Her more than 20 years of leadership experience and track record of success across multiple healthcare markets, as well as her demonstrated passion for patient centricity, will serve as a critical foundation during Takeda's global transformation."

Sequeira brings extensive leadership experience across multiple therapy areas including neuroscience, specialty and primary care, and several regions including the U.S., Canada and U.K. Her most recent role was as vice president, Eli Lilly. Previously, she was the general manager of Lilly's U.K. Hub.

She will assume the role as Takeda U.S. president on June 1.